320 related articles for article (PubMed ID: 21492998)
21. Intraperitoneal cerebrospinal fluid pseudocyst. A rare complication of ventriculoperitoneal shunt.
Birbilis T; Kontogianidis K; Matis G; Theodoropoulou E; Efremidou E; Argyropoulou P
Chirurgia (Bucur); 2008; 103(3):351-3. PubMed ID: 18717287
[TBL] [Abstract][Full Text] [Related]
22. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Arnell K; Enblad P; Wester T; Sjölin J
J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
[TBL] [Abstract][Full Text] [Related]
23. Unexpected eosinophilia in children affected by hydrocephalus accompanied with shunt infection.
Polis B; Polis L; Zeman K; Paśnik J; Nowosławska E
Childs Nerv Syst; 2018 Dec; 34(12):2399-2405. PubMed ID: 30032408
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
[TBL] [Abstract][Full Text] [Related]
25. Cerebro-spinal fluid eosinophilia in shunt infections.
Vinchon M; Vallee L; Prin L; Desreumaux P; Dhellemmes P
Neuropediatrics; 1992 Oct; 23(5):235-40. PubMed ID: 1454141
[TBL] [Abstract][Full Text] [Related]
26. [Liver abscess secondary to ventriculoperitoneal shunt].
Kohno K; Kagawa Y; Takeda S
No Shinkei Geka; 1987 May; 15(5):575-9. PubMed ID: 3627372
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic importance of eosinophil granulocytes in the CSF of children with ventricular-peritoneal shunt systems.
Wiersbitzky SK; Ahrens N; Becker T; Panzig B; Abel J; Stenger RD
Acta Neurol Scand; 1998 Mar; 97(3):201-3. PubMed ID: 9531438
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria.
Arnell K; Cesarini K; Lagerqvist-Widh A; Wester T; Sjölin J
J Neurosurg Pediatr; 2008 May; 1(5):366-72. PubMed ID: 18447670
[TBL] [Abstract][Full Text] [Related]
30. Progression of cerebrospinal fluid cell count and differential over a treatment course of shunt infection.
Fulkerson DH; Sivaganesan A; Hill JD; Edwards JR; Shoja MM; Boaz JC; Jea A
J Neurosurg Pediatr; 2011 Dec; 8(6):613-9. PubMed ID: 22132920
[TBL] [Abstract][Full Text] [Related]
31. Early programmable valve malfunctions in pediatric hydrocephalus.
Mangano FT; Menendez JA; Habrock T; Narayan P; Leonard JR; Park TS; Smyth MD
J Neurosurg; 2005 Dec; 103(6 Suppl):501-7. PubMed ID: 16383248
[TBL] [Abstract][Full Text] [Related]
32. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
33. Shunt infection: is there a near-miss scenario?
Thompson DN; Hartley JC; Hayward RD
J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
[TBL] [Abstract][Full Text] [Related]
34. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections.
Hampl JA; Weitzel A; Bonk C; Kohnen W; Roesner D; Jansen B
Infection; 2003 Mar; 31(2):109-11. PubMed ID: 12682816
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid shunt complications: an emergency medicine perspective.
Key CB; Rothrock SG; Falk JL
Pediatr Emerg Care; 1995 Oct; 11(5):265-73. PubMed ID: 8570446
[TBL] [Abstract][Full Text] [Related]
36. Infection after Harare valve V-P shunt operations: a review of 92 cases.
Sibanda EN; Levy LF; Makarawo S
Cent Afr J Med; 1991 Dec; 37(12):397-403. PubMed ID: 1806253
[TBL] [Abstract][Full Text] [Related]
37. Eosinophilia of the cerebrospinal fluid in a case of shunt infection: case report.
Mine S; Sato A; Yamaura A; Tamachi S; Makino H; Tomioka H
Neurosurgery; 1986 Nov; 19(5):835-6. PubMed ID: 3785637
[TBL] [Abstract][Full Text] [Related]
38. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
James HE; Bradley JS
Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
[TBL] [Abstract][Full Text] [Related]
39. The value of C-reactive protein in the management of shunt infections.
Schuhmann MU; Ostrowski KR; Draper EJ; Chu JW; Ham SD; Sood S; McAllister JP
J Neurosurg; 2005 Sep; 103(3 Suppl):223-30. PubMed ID: 16238075
[TBL] [Abstract][Full Text] [Related]
40. [Complications of cerebrospinal fluid shunt].
Gómez López L; Luaces Cubells C; Costa Clará JM; Palá Calvo MT; Martín Rodrigo JM; Palomeque Rico A; Pou Fernández J
An Esp Pediatr; 1998 Apr; 48(4):368-70. PubMed ID: 9629793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
